6 Mar'26 Portfolio
Doubling down on the risk-off stance
Vish (Hunting Alphas)
Pfizer: Obesity Hype And Vaccine Policy Shocks (Archive)
Pfizer’s obesity and vaccine setbacks outweigh cheap valuation, pointing to renewed underperformance risk.
China’s AI Infrastructure Play Riding Railways, Power Grids and Airports
AI-powered infrastructure inspections across railways, energy grids, and emerging airport docking systems.
27 Feb'26 Portfolio And Early March Changes
Shifting to defense amid Iran conflict and oil price shocks on net-importer Japan.
Portfolio Performance - Feb'26
Feb'26: >9% annualized alpha, Sortino 2.5, IR 1.0, rare factor exposures style, low drawdowns. Strategy scalable to >$100M AUM. Live real-money.
20 Feb'26 Portfolio
A shift from the US to Japan
Portfolio Performance - Jan'26
Jan'26: >11% alpha, Sortino 3.0, IR 1.2, rare factor exposures style, low drawdowns. Strategy scalable to >$100M AUM. Live real-money.